T-cell Modulating Therapy

T-Cell Modulating Therapy is a pharmacotherapeutic strategy within neuroinflammatory disorder treatment that selectively alters T-cell activation, proliferation, or function to restore immune homeostasis and mitigate central nervous system inflammation.

32

Publications

1.7K

Citations

232

Authors

109

Institutions

Publications per year

2017–2026

11

Authors

232

  1. JN
    Jianqin Niu

    Army Medical University, China

    1 publications · 52 citations

    1

    h-index

  2. WC
    Wenjie Chen

    Sun Yat-sen University, China

    1 publications · 29 citations

    1

    h-index

  3. SG
    Scott Gettinger

    Yale Cancer Center, United States

    1 publications · 51 citations

    1

    h-index

  4. RA
    Ruth Arnon

    Weizmann Institute of Science, Israel

    1 publications · 232 citations

    1

    h-index

  5. RG
    Richard G. Sheahan

    The University of Texas Medical Branch at Galveston, United States

    1 publications · 22 citations

    1

    h-index

1–5 of 232

Venues

  1. Proceedings of the National Academy of Sciences

    PNAS · 2 publications · 264 citations

    2

    h-index

  2. Journal of Neuroimmunology

    JNI · 2 publications · 145 citations

    2

    h-index

  3. International Immunopharmacology

    2 publications · 118 citations

    2

    h-index

  4. PLoS ONE

    2 publications · 218 citations

    2

    h-index

  5. Cancer Immunology Research

    2 publications · 73 citations

    2

    h-index

1–5